- Taking aim at triple-negative breast cancer and multiple myeloma to improve prognoses EurekAlert
- Daratumumab Resistance in Multiple Myeloma May Be Associated With High Levels of NHE6 Expression Pharmacy Times
- View Full coverage on Google News
Taking aim at triple-negative breast cancer and multiple myeloma to improve prognoses – EurekAlert
ByGoogle News
Sep 27, 2022